Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matt Shirley

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Targeted Oncology|March 5, 2019
Rucaparib: A Review in Ovarian CancerMatt Shirley
Drugs|May 13, 2024
Correction: Vonoprazan: A Review in Helicobacter pylori InfectionMatt Shirley
Drugs|October 15, 2018
Dinoprostone Vaginal Insert: A Review in Cervical RipeningMatt Shirley
Drugs|April 16, 2021
Casimersen: First ApprovalMatt Shirley
Drugs|March 19, 2024
Correction: Zilucoplan: First ApprovalMatt Shirley
Drugs|May 27, 2017
Dupilumab: First Global ApprovalMatt Shirley
Drugs|July 12, 2018
Avatrombopag: First Global ApprovalMatt Shirley
Drugs|August 18, 2018
Encorafenib and Binimetinib: First Global ApprovalsMatt Shirley
Targeted Oncology|May 19, 2023
Correction to: Relugolix: A Review in Advanced Prostate CancerMatt Shirley
Drugs|February 22, 2024
Capivasertib: First ApprovalMatt Shirley
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Targeted Oncology|March 5, 2019
Rucaparib: A Review in Ovarian CancerMatt Shirley
Drugs|May 13, 2024
Correction: Vonoprazan: A Review in Helicobacter pylori InfectionMatt Shirley
Drugs|October 15, 2018
Dinoprostone Vaginal Insert: A Review in Cervical RipeningMatt Shirley
Drugs|April 16, 2021
Casimersen: First ApprovalMatt Shirley
Drugs|March 19, 2024
Correction: Zilucoplan: First ApprovalMatt Shirley
Drugs|May 27, 2017
Dupilumab: First Global ApprovalMatt Shirley
Drugs|July 12, 2018
Avatrombopag: First Global ApprovalMatt Shirley
Drugs|August 18, 2018
Encorafenib and Binimetinib: First Global ApprovalsMatt Shirley
Targeted Oncology|May 19, 2023
Correction to: Relugolix: A Review in Advanced Prostate CancerMatt Shirley
Drugs|February 22, 2024
Capivasertib: First ApprovalMatt Shirley
Pageof 9